Ketol-acid reductoisomerase using NADH
View Patent ↗Methods for the evolution of NADPH binding ketol-acid reductoisomerase enzymes to acquire NADH binding functionality are provided. Specific mutant ketol-acid reductoisomerase enzymes isolated from Pseudomonas that have undergone co-factor switching to bind NADH are described.
1. A recombinant mutant ketol-acid reductoisomerase (KARI) enzyme of SEQ ID NO: 63, wherein said enzyme has a ketol-acid reductoisomerase HMM search profile E value of <10 −3 using the hmmsearch program and comprises at least one mutation within the phosphate binding loop of said enzyme wherein said at least one mutation comprises a substitution at the residue corresponding to T52 of SEQ ID NO:17 wherein the substitution at the corresponding residue to T52 is a substitution to a polar, negatively charged amino acid.
2. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises at least one substitution at a residue corresponding to 24, 33, 47, 50, 52, 53, 61, 80, 115, 156, 165, or 170 of SEQ ID NO:17.
3. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 47 of SEQ ID NO:17, wherein the substitution is to an amino acid selected from the group consisting of A, C, D, F, G, I, L, N, P, and Y.
4. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 50 of SEQ ID NO:17, wherein the substitution is to an amino acid selected from the group consisting of A, C, D, E, F, G, M, N, V, and W.
5. The recombinant mutant KARI enzyme of claim 1 , wherein the substitution at the corresponding residue to T52 of SEQ ID NO:17 is to D.
6. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 53 of SEQ ID NO:17, wherein the substitution is to an amino acid substitution selected from the group consisting of A, H, I, and W.
7. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 156 of SEQ ID NO:17, wherein the substitution is to V.
8. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 165 of SEQ ID NO:17, wherein the substitution is to M.
9. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 61 of SEQ ID NO:17, wherein the substitution is to F.
10. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 170 of SEQ ID NO:17, wherein the substitution is to A.
11. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 24 of SEQ ID NO:17, wherein the substitution is to F.
12. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 33 of SEQ ID NO:17, wherein the substitution is to L.
13. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 80 of SEQ ID NO:17, wherein the substitution is to I.
14. The recombinant mutant KARI enzyme of claim 1 , wherein the enzyme further comprises a substitution at a residue corresponding to amino acid 115 of SEQ ID NO:17, wherein the substitution is to L.